Deepak Agarwal, MD
Urology · Indianapolis, INNPI 1972919538
Payments from drug & device makers
Across 35 payments — averaging $206.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Richard Wolf Medical Instruments Corp.$3K
- Calyxo, Inc.$2K
- Boston Scientific$2K
- Abbott$370
- Cook Medical LLC$364
- KARL Storz Endoscopy-america$158
- plus $34 from 2 others
What the payments were for
- Consulting fees$81011%
- Speaking & faculty fees$1,50021%
- Travel & lodging$2,44734%
- Food & beverage$2,48234%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Richard Wolf Medical Instruments Corp. | 6 | $2,845 |
| Calyxo, Inc. | 8 | $1,849 |
| Boston Scientific | 10 | $1,618 |
| Abbott | 4 | $370 |
| Cook Medical LLC | 3 | $364 |
| KARL Storz Endoscopy-america | 2 | $158 |
| Vertos Medical, Inc. | 1 | $19 |
| Ambu Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CVAC Aspiration System$1,679
- GENERAL KIDNEY STONE DISEASE$1,034
- Medical Instrumentation$1,010
- LITHO 150$286
- LithoVue$175
- Proclaim DRG IPG$116
- GENERAL - THERAPIES$111
How this compares
$7,238 in reported general payments places this provider in the 65th percentile of 272 urology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 29 | $22,069 |
| GemtesaVibegron | 30 | $18,778 |
| Potassium Citrate ErPotassium Citrate | 31 | $3,797 |
| Tolterodine Tartrate ErTolterodine Tartrate | 46 | $2,291 |
| Tamsulosin Hcl | 144 | $2,214 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 39 | $1,256 |
| Finasteride | 38 | $785 |
| Trospium Chloride | 13 | $606 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 34 | $534 |
| Potassium Chloride | 12 | $246 |
| Cephalexin | 45 | $193 |
| Oxybutynin Chloride ErOxybutynin Chloride | 26 | $149 |
| Oxycodone Hcl | 49 | $108 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 19 | $101 |
| Ciprofloxacin Hcl | 22 | $89 |
Paid to pharmacies, not to this prescriber.
Other urology in Indianapolis
- Marcelino RiveraIndianapolis$382K
- Hristos KaimakliotisIndianapolis$316K
- Michael BorofskyIndianapolis$244K
- Helen BernieIndianapolis$162K
- Chandru SundaramIndianapolis$75K
- Austen SladeIndianapolis$73K
- Charles PowellIndianapolis$66K
- Jacob RustIndianapolis$57K
- Alvin WeeIndianapolis$46K
- Jason SprungerIndianapolis$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.